Perfuze secures FDA clearance for stroke treatment catheters and €22M funding
Irish medical device company Perfuze has achieved two significant milestones in advancing acute ischemic stroke treatment technology. The firm has received FDA 510(k) clearance for its Zipline™ Access Catheters alongside securing €22 million in follow-on funding to support commercial rollout and ongoing research initiatives.